Kidney Stone

Nephrology
1
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Boehringer Ingelheim
Boehringer IngelheimINGELHEIM, Germany
1 program
1
Empagliflozin 25 MGPhase 21 trial
Active Trials
NCT04911660Completed50Est. Apr 2023
Olympus
OlympusPA - Center Valley
1 program
SOLTIVE™ Premium SuperPulsed Laser Fiber SystemN/A1 trial
Active Trials
NCT04556201Completed450Est. May 2023
Calyxo
CalyxoCA - Pleasanton
1 program
SUREN/A1 trial
Active Trials
NCT04519294Completed132Est. Apr 2025
Alliance Pharmaceuticals
1 program
Super-mini percutaneous nephrolithotomyN/A1 trial
Active Trials
NCT04317443Unknown250Est. Sep 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Boehringer IngelheimEmpagliflozin 25 MG
CalyxoSURE
OlympusSOLTIVE™ Premium SuperPulsed Laser Fiber System
Alliance PharmaceuticalsSuper-mini percutaneous nephrolithotomy

Clinical Trials (4)

Total enrollment: 882 patients across 4 trials

Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers

Start: Aug 2021Est. completion: Apr 202350 patients
Phase 2Completed

Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE)

Start: Jun 2021Est. completion: Apr 2025132 patients
N/ACompleted
NCT04556201OlympusSOLTIVE™ Premium SuperPulsed Laser Fiber System

The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones

Start: Dec 2020Est. completion: May 2023450 patients
N/ACompleted
NCT04317443Alliance PharmaceuticalsSuper-mini percutaneous nephrolithotomy

A Prospective Observational Comparison of SMP and ESWL for the Treatment of Renal Stones ≥20 mm in Children (IAU-04)

Start: May 2020Est. completion: Sep 2021250 patients
N/AUnknown

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 companies competing in this space